NDC11 85477073007
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 85477-0730-07 | 85477-0730 |
| 85477-0730-7 | 85477-0730 |
| 85477-730-07 | 85477-730 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LidexaGel 5% | LIDOCAINE HCL | Oncora Pharma, LLC | b45a7d2f-111f-4390-9b90-570b1c9f5ffc | 2026-07-08 | Warnings, Adverse reactions | 85477-730-07 85477-730 85477073007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.